Company Overview
About Cure HHT
Cure HHT is a non-profit organization dedicated to finding a cure for hereditary hemorrhagic telangiectasia (HHT), a genetic blood vessel disorder affecting 1 in 5,000 people, 90% of whom remain undiagnosed. The organization's mission is to support research, provide resources, and raise awareness about HHT within the medical community and the public.
More Companies in Maryland
Browse all companies in Maryland →
Frequently Asked Questions about Cure HHT
Technologies Used
Social Profiles
Key Decision Makers
Alicia Hall Clinical Trial Manager/Clinical Operations Lead